These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Two-dimensional NMR spectroscopy of urinary glycosaminoglycans from patients with different mucopolysaccharidoses. Hochuli M, Wüthrich K, Steinmann B. NMR Biomed; 2003 Jun; 16(4):224-36. PubMed ID: 14558120 [Abstract] [Full Text] [Related]
5. The mucopolysaccharidoses: a success of molecular medicine. Clarke LA. Expert Rev Mol Med; 2008 Jan 18; 10():e1. PubMed ID: 18201392 [Abstract] [Full Text] [Related]
6. [Pathomorphology of mucopolysaccharidoses]. Warzok R, Wattig B, Seidlitz G. Zentralbl Allg Pathol; 1990 Jan 18; 136(1-2):43-57. PubMed ID: 2109439 [Abstract] [Full Text] [Related]
7. [Mucopolysaccharidoses. New therapeutic possibilities increase the need of early diagnosis]. Malm G, Bondeson ML, von Döbeln U, Månsson JE. Lakartidningen; 2002 Apr 18; 99(16):1804-9. PubMed ID: 12043480 [Abstract] [Full Text] [Related]
8. Corneal manifestations of the systemic mucopolysaccharidoses. Sugar J. Ann Ophthalmol; 1979 Apr 18; 11(4):531-5. PubMed ID: 156516 [Abstract] [Full Text] [Related]
10. Overview of the mucopolysaccharidoses. Muenzer J. Rheumatology (Oxford); 2011 Dec 18; 50 Suppl 5():v4-12. PubMed ID: 22210669 [Abstract] [Full Text] [Related]
11. Mucopolysaccharidosis III A (Sanfilippo disease type A). Histochemical, electron microscopical and biochemical findings. Cain H, Egner E, Kresse H. Beitr Pathol; 1977 Apr 18; 160(1):58-72. PubMed ID: 405006 [Abstract] [Full Text] [Related]
15. Musculoskeletal complications encountered in the lysosomal storage disorders. Pastores GM. Best Pract Res Clin Rheumatol; 2008 Oct 18; 22(5):937-47. PubMed ID: 19028373 [Abstract] [Full Text] [Related]
16. Glycosaminoglycan accumulation and excretion in the mucopolysaccharidoses: characterization and basis of a diagnostic test for MPS. Byers S, Rozaklis T, Brumfield LK, Ranieri E, Hopwood JJ. Mol Genet Metab; 1998 Dec 18; 65(4):282-90. PubMed ID: 9889015 [Abstract] [Full Text] [Related]
18. [Mucopolysaccharidoses--biochemical mechanisms of diseases and therapeutic possibilities]. Kloska A, Tylki-Szymańska A, Wegrzyn G. Postepy Biochem; 2011 Dec 18; 57(2):133-47. PubMed ID: 21913414 [Abstract] [Full Text] [Related]
19. [Phenotype of mucopolysaccharidoses. A warning: mucopolysaccharidosis is not called gargoylism!]. Kircher S, Lubec G, Kraft M. Padiatr Padol; 1988 Dec 18; 23(1):61-80. PubMed ID: 3133629 [Abstract] [Full Text] [Related]
20. Mice lacking both subunits of lysosomal beta-hexosaminidase display gangliosidosis and mucopolysaccharidosis. Sango K, McDonald MP, Crawley JN, Mack ML, Tifft CJ, Skop E, Starr CM, Hoffmann A, Sandhoff K, Suzuki K, Proia RL. Nat Genet; 1996 Nov 18; 14(3):348-52. PubMed ID: 8896570 [Abstract] [Full Text] [Related] Page: [Next] [New Search]